8-K: UHT Q3 2025 Earnings: FFO Up, Net Income Flat

Universal Health Realty Income Trust reported flat net income for Q3 2025 but an increase in Funds From Operations, alongside a new medical office building development.

Summary

• Net income for the three-month period ended September 30, 2025, was $4.0 million, or $.29 per diluted share, which is flat compared to the third quarter of 2024.
• Funds From Operations (FFO) for Q3 2025 increased by $908,000, or $.06 per diluted share, to $12.2 million, or $.88 per diluted share, compared to $11.3 million, or $.82 per diluted share, in Q3 2024.
• Net income for the nine-month period ended September 30, 2025, was $13.3 million, or $.96 per diluted share, a decrease from $14.6 million, or $1.05 per diluted share, during the comparable period of 2024.
• FFO for the first nine months of 2025 decreased by $166,000, or $.02 per diluted share, to $35.9 million, or $2.59 per diluted share, compared to $36.1 million, or $2.61 per diluted share, in the comparable period of 2024.
• A third quarter dividend of $.74 per share, totaling $10.3 million, was declared on September 22, 2025, and paid on September 30, 2025.
• As of September 30, 2025, there was $67.9 million of available borrowing capacity under the $425 million credit agreement, which is scheduled to expire on September 30, 2028.
• A ground lease was entered into in October 2025 with a wholly-owned subsidiary of UHS to develop, construct, and own Palm Beach Gardens Medical Plaza I, an 80,000 square foot medical office building (MOB) with an estimated cost of $34 million.

Sentiment

Score: 6

Explanation: Q3 FFO growth and the new development project are positive indicators of operational strength and strategic expansion. However, the decline in nine-month net income and FFO, coupled with increased interest expense and various industry-wide risks, presents a mixed financial picture that tempers overall sentiment.

Positives

• Q3 2025 Funds From Operations (FFO) increased by $908,000, or $.06 per diluted share, to $12.2 million ($.88/diluted share), demonstrating operational growth.
• A one-time settlement and release agreement contributed $275,000 ($.02/diluted share) to Q3 2025 net income.
• Secured a ground lease for Palm Beach Gardens Medical Plaza I, a new 80,000 sq ft medical office building, with construction expected to commence in November 2025, indicating strategic expansion.
• A wholly-owned subsidiary of UHS has executed a 10-year master flex lease for approximately 75% of the rentable square feet of the new medical office building, providing significant pre-leasing commitment.
• Maintained $67.9 million of available borrowing capacity as of September 30, 2025, under the existing credit agreement.

Negatives

• Net income for the nine-month period ended September 30, 2025, decreased by $1.3 million, or $.09 per diluted share, compared to the comparable period of 2024.
• Funds From Operations (FFO) for the first nine months of 2025 decreased by $166,000, or $.02 per diluted share, compared to the comparable period of 2024.
• Q3 2025 net income included approximately $900,000 of nonrecurring depreciation expense.
• The nine-month 2025 net income was negatively impacted by a $563,000 ($.04/diluted share) property tax reduction recorded in 2024 that did not recur in 2025.
• Interest expense increased by $282,000 ($.02/diluted share) during the first nine months of 2025, primarily due to an increase in average borrowings outstanding.

Risks

• Potential significant reductions in federal funding for state Medicaid programs and/or other changes, which could result in reduced Medicaid payments to facility operators.
• Decreases in staffing availability and related increases to wage expense experienced by tenants due to shortages of nurses and other clinical staff and support personnel.
• The impact of government and administrative regulation of the healthcare industry.
• Declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions, including increases in uninsured and underinsured patients.
• Potential cost increases and disruptions related to supplies and building materials resulting from changes in laws or policies governing foreign trade, such as increased trade restrictions, tariffs, or taxes on imports.
• Increased borrowing costs and reduced ability to access capital markets on favorable terms due to rising interest rates.
• Additional increases in interest rates could have a significant unfavorable impact on future results of operations and adversely affect the ability to carry out strategy.

Future Outlook

Construction of Palm Beach Gardens Medical Plaza I is expected to commence in November 2025. The Alan B. Miller Medical Center, on whose campus the MOB will be located, is scheduled for completion and opening during the third quarter of 2026. The existing $425 million credit agreement has an option to be extended for up to two additional six-month periods.

Management Comments

• Management believes that adjusted net income and adjusted net income per diluted share, as non-GAAP financial measures, are helpful to investors as measures of operating performance.
• Management believes that Funds From Operations (FFO) and FFO per diluted share, as non-GAAP financial measures, are helpful to investors as measures of operating performance.

Industry Context

The company operates as a Real Estate Investment Trust (REIT) specializing in healthcare and human-service related facilities. The development of a new medical office building on a hospital campus aligns with broader industry trends towards integrated healthcare delivery and outpatient services. The identified risks, such as federal funding changes for Medicaid, healthcare staffing shortages, and rising interest rates, are prevalent challenges impacting both the healthcare and real estate sectors, particularly for REITs focused on specialized properties.

Comparison to Industry Standards

• NA

Related Party Transactions

• Entered into a ground lease with a wholly-owned subsidiary of UHS for the development of Palm Beach Gardens Medical Plaza I.
• Engaged a wholly-owned subsidiary of UHS to act as project manager for the construction of Palm Beach Gardens Medical Plaza I.
• A wholly-owned subsidiary of UHS has executed a 10-year master flex lease agreement for approximately 75% of the rentable square feet of Palm Beach Gardens Medical Plaza I.
• Lease revenue from UHS facilities totaled $8,367 thousand for Q3 2025 and $25,075 thousand for the nine months ended September 30, 2025.
• Other revenue from UHS facilities totaled $233 thousand for Q3 2025 and $699 thousand for the nine months ended September 30, 2025.
• Interest income on financing leases from UHS facilities totaled $1,348 thousand for Q3 2025 and $4,050 thousand for the nine months ended September 30, 2025.
• Advisory fees paid to UHS totaled $1,414 thousand for Q3 2025 and $4,169 thousand for the nine months ended September 30, 2025.
• Financing receivable from UHS was $82,315 thousand as of September 30, 2025.
• Lease and other receivables from UHS were $6,985 thousand as of September 30, 2025.

Stakeholder Impact

• Shareholders: Received a $.74 per share dividend, experienced flat Q3 net income but increased Q3 FFO, and face mixed nine-month financial results alongside future growth prospects from new developments.
• Tenants: Face challenges from potential reductions in Medicaid funding, staffing shortages, and macroeconomic conditions that could impact patient volumes and payer mix.
• Creditors: The company maintains available borrowing capacity under its credit agreement, but increased interest expense impacts financial performance.
• Employees (of tenants): The filing highlights a shortage of nurses and other clinical staff and support personnel, leading to increased wage expenses for tenants.

Next Steps

• Commencement of construction for Palm Beach Gardens Medical Plaza I in November 2025.
• Completion and opening of the Alan B. Miller Medical Center during the third quarter of 2026.
• Potential exercise of the option to extend the $425 million credit agreement for up to two additional six-month periods.

Key Dates

Recommendation

While Q3 FFO showed growth and a new development project is underway, the nine-month financial performance indicates a slight decline in net income and FFO, partly due to non-recurring items and increased interest expense. The company faces significant industry-wide risks, including healthcare funding changes, staffing shortages, and rising interest rates. The new development provides future growth potential, but current financial trends are mixed, suggesting a 'hold' position until clearer positive momentum or risk mitigation strategies are evident.

Keywords

REIT, Healthcare Real Estate, Medical Office Building, UHT, Earnings Report, Q3 2025, FFO, Net Income, Dividend, Real Estate Investment Trust, Healthcare Facilities, Universal Health Realty Income Trust, Palm Beach Gardens Medical Plaza I, UHS